Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
The company manufactures pharmaceutical products such as aminoglycosides, anti-tuberculosis, anti-hypertensive, anti-malarial, anti-scabies, anti-diabetics, anti-diarrhoeals, anti-histamine
Aristo Pharmaceuticals Private Limited, is an unlisted private company incorporated on 08 November, 1971. It is classified as a private limited company and is located in Mumbai City, Maharashtra. It's authorized share capital is INR 99.00 lac and the total paid-up capital is INR 98.97 lac.
Read more
This action will use 1 of your credits. Are you sure you want to go ahead?
** All rupee values in INR crores. Based on March 2024 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
State | Type | Address |
---|
Read more
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Sales | 3,025.4 | 3,016.7 | 4,098.7 | 4,365.3 | 4,750.0 |
Operating profit | 891.9 | 1,083.3 | 1,457.8 | 1,499.5 | 1,655.6 |
Net profit | 725.9 | 901.2 | 1,244.2 | 1,254.0 | 1,466.3 |
Gross margin | 60.8 | 63.7 | 62.1 | 63.5 | 65.5 |
Operating margin | 29.5 | 35.9 | 35.6 | 34.4 | 34.9 |
Net margin | 23.0 | 28.5 | 29.2 | 27.6 | 28.8 |
Networth | 2,927.0 | 3,461.3 | 4,260.0 | 5,070.1 | 6,040.2 |
Borrowings | - | - | - | - | - |
Assets | 3,467.1 | 3,906.4 | 4,741.9 | 5,586.6 | 6,599.2 |
Debt to equity | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Current ratio | 2.4 | 4.9 | 7.3 | 4.5 | 10.1 |
ROE | 24.8 | 26.0 | 29.2 | 24.7 | 24.3 |
Days payable | 94.0 | 70.0 | 64.0 | 49.0 | 55.0 |
WC days | 70.0 | 150.0 | 200.0 | 101.0 | 275.0 |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Equity Capital | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 |
Reserves | 2,926.0 | 3,460.3 | 4,259.0 | 5,069.1 | 6,039.2 |
Borrowings + | - | - | - | - | - |
Long term borrowings | - | - | - | - | - |
Short term borrowings | - | - | - | - | - |
Trade payables + | 304.5 | 209.0 | 271.5 | 215.0 | 246.4 |
Days payable | 94.0 | 70.0 | 64.0 | 49.0 | 55.0 |
Other liabilities + | 540.1 | 445.1 | 481.9 | 516.5 | 559.0 |
Other non-current liabilities | 135.0 | 124.4 | 123.8 | 166.2 | 165.8 |
Other current liabilities | 100.6 | 111.6 | 86.5 | 135.3 | 146.7 |
Total liabilities | 3,467.1 | 3,906.4 | 4,741.9 | 5,586.6 | 6,599.2 |
Fixed Assets + | 539.7 | 485.5 | 458.7 | 485.8 | 482.3 |
Tangible assets | 515.6 | 475.8 | 451.2 | 474.8 | 461.6 |
CWIP | 21.7 | 7.3 | 6.0 | 10.1 | 19.1 |
Intangible assets | 2.4 | 2.4 | 1.4 | 0.8 | 1.6 |
LT loans and advances | - | - | - | - | - |
Other non-current assets | 1,942.1 | 1,863.2 | 1,679.1 | 3,543.4 | 2,145.3 |
Current assets + | 985.2 | 1,557.7 | 2,604.1 | 1,557.3 | 3,971.6 |
Inventories | 493.0 | 582.1 | 681.6 | 734.2 | 836.2 |
Trade receivables | 93.3 | 53.7 | 58.4 | 58.2 | 52.1 |
Cash and cash equivalents | 256.0 | 15.9 | 23.3 | 50.3 | 53.3 |
ST loans and advances | 0.3 | 0.2 | 0.5 | 0.2 | 0.2 |
Other current assets | 142.6 | 905.9 | 1,840.4 | 714.4 | 3,029.9 |
Total assets | 3,467.1 | 3,906.4 | 4,741.9 | 5,586.6 | 6,599.2 |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Sales + | 3,025.4 | 3,016.7 | 4,098.7 | 4,365.3 | 4,750.0 |
Sales growth % | 16.35 | -0.29 | 35.87 | 6.5 | 8.81 |
Expenses + | 2,216.1 | 2,012.4 | 2,712.4 | 2,940.6 | 3,174.2 |
Cost of goods | 1,185.8 | 1,094.1 | 1,554.4 | 1,595.0 | 1,639.9 |
Employee cost | 447.6 | 476.5 | 585.4 | 658.7 | 700.0 |
Other costs | 500.1 | 362.7 | 501.1 | 612.2 | 754.5 |
Operating profit + | 891.9 | 1,083.3 | 1,457.8 | 1,499.5 | 1,655.6 |
Operating margin % | 29.5 | 35.9 | 35.6 | 34.4 | 34.9 |
Other income | 135.6 | 150.1 | 166.8 | 179.7 | 344.3 |
Interest | 8.5 | 7.8 | 6.7 | 8.8 | 10.6 |
Depreciation | 74.1 | 71.2 | 64.9 | 66.0 | 69.2 |
Exceptional items | - | - | - | - | - |
Profit before tax | 944.9 | 1,154.4 | 1,553.0 | 1,604.4 | 1,920.1 |
Tax | 219.0 | 253.2 | 308.8 | 350.4 | 453.8 |
Profit - disc. ops | - | - | - | - | - |
Net profit | 725.9 | 901.2 | 1,244.2 | 1,254.0 | 1,466.3 |
Net margin % | 23.0 | 28.5 | 29.2 | 27.6 | 28.8 |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Solvency + | |||||
Total Debt/Equity | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Net Debt/Equity | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Total Debt/Assets | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Total Assets/Equity | 1.2 | 1.1 | 1.1 | 1.1 | 1.1 |
Liquidity + | |||||
Current Ratio | 2.4 | 4.9 | 7.3 | 4.5 | 10.1 |
Quick Ratio | 1.2 | 3.0 | 5.4 | 2.4 | 8.0 |
Interest Coverage | 104.4 | 139.0 | 217.4 | 170.7 | 155.7 |
Performance | |||||
Gross Margin | 60.8 | 63.7 | 62.1 | 63.5 | 65.5 |
Operating Margin | 29.5 | 35.9 | 35.6 | 34.4 | 34.9 |
Net Margin | 23.0 | 28.5 | 29.2 | 27.6 | 28.8 |
Return + | |||||
Return on Equity | 24.8 | 26.0 | 29.2 | 24.7 | 24.3 |
Pre-tax ROCE | 73.0 | 58.8 | 51.5 | 84.7 | 39.1 |
Return on Assets | 20.9 | 23.1 | 26.2 | 22.4 | 22.2 |
Pre-tax ROIC | 27.9 | 29.2 | 32.7 | 28.3 | 26.3 |
Efficiency + | |||||
Days Payable | 94.0 | 70.0 | 64.0 | 49.0 | 55.0 |
Days Inventory | 152.0 | 194.0 | 160.0 | 168.0 | 186.0 |
Days Receivable | 11.0 | 6.0 | 5.0 | 5.0 | 4.0 |
Fixed Asset Turnover | 5.6 | 6.2 | 8.9 | 9.0 | 9.8 |
Total Asset Turnover | 0.9 | 0.8 | 0.9 | 0.8 | 0.7 |
Working Capital | |||||
Cash Conversion Cycle | 69.0 | 130.0 | 101.0 | 124.0 | 135.0 |
Working Capital Days | 70.0 | 150.0 | 200.0 | 101.0 | 275.0 |
As per information available, the company has no registered charges.
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Whole-time Director | Randhir Kumar Bachan | 01163058 | 20 years |
Managing Director | Umesh Sharma | 01385819 | 46 years |
Director | Virendra Sharma | 01449416 | 19 years |
Name | Status | Paid up Capital | Common Directors | Address |
---|---|---|---|---|
MAPRA LABORATORIES PVT LTD |
Active
|
15.0 L | 1 | Maharashtra |
ARISTO LABORATORIES PRIVATE LIMITED |
Active
|
99.0 L | 2 | Maharashtra |
ROSEWELL PHARMACEUTICALS PRIVATE LIMITED |
Active
|
15.0 L | 1 | Maharashtra |
RAHUL INDUSTRIES PRIVATE LIMITED |
Under Process of Striking Off
|
1.0 L | 1 | Bihar |
NOBEL ENKEM PRIVATE LIMITED |
Active
|
7.9 L | 1 | Bihar |
OTSIRA PARENTERAL PVT.LTD. |
Under Process of Striking Off
|
1.0 L | 1 | Bihar |
The incorporation date of ARISTO PHARMACEUTICALS PRIVATE LIMITED is 08 November, 1971
The authorized share capital of ARISTO PHARMACEUTICALS PRIVATE LIMITED is INR ₹ 99.0 L.
The paid-up capital of ARISTO PHARMACEUTICALS PRIVATE LIMITED is INR ₹ 99.0 L.
The registered address of ARISTO PHARMACEUTICALS PRIVATE LIMITED is Gala No.2,Ground Floor,23-A Shah Industrial Estate Off Veera Desai Road, Andheri(West), Mumbai 40005 MUMBAI Mumbai City Maharashtra - 400053
The CIN number of ARISTO PHARMACEUTICALS PRIVATE LIMITED is U24239MH1971PTC015425.